|
市場調査レポート
商品コード
1360050
北米の臨床試験イメージング市場の2028年までの予測-地域別分析：モダリティ、オファリング、エンドユーザー別North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User |
||||||
|
|
|||||||
| 北米の臨床試験イメージング市場の2028年までの予測-地域別分析：モダリティ、オファリング、エンドユーザー別 |
|
出版日: 2023年07月27日
発行: The Insight Partners
ページ情報: 英文 124 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
北米の臨床試験イメージング市場は、2023年の7億494万米ドルから2028年には10億2,561万米ドルに成長すると予測され、2023年から2028年までのCAGRは7.8%と推定されます。
医療画像サービスを提供するCRO数の急増が北米臨床試験画像市場を後押し
臨床研究機関（CRO）は、高品質な施設と深い専門知識を駆使して提供するサービスを通じて、臨床試験の成功を支援しています。CROは、効率的で費用対効果の高い業務を通じて治験依頼者に利益をもたらし、臨床試験業界の屋台骨として機能し始めています。例えば、CROが臨床試験を実施し完了するまでに要する時間は、社内活動よりも平均して30％短いです。CROの数が増加し競争が激しくなる中、一部のCROはイメージングに特化したサービスを提供し、イメージングCRO（iCRO）として台頭してきています。iCROの例としては、Keosys Medical ImagingやMedica Group PLCなどが挙げられます。CROは、イメージング実施施設の認定、標準化された画像の取得、読影デザインと基準の決定などの分野で重要な知識を提供し、北米の臨床試験イメージング市場全体の成長に貢献しています。
北米臨床試験イメージング市場概要
北米の臨床試験イメージング市場は、米国、カナダ、メキシコに区分されます。米国は臨床試験イメージング市場において最大かつ急成長している市場です。同地域の市場成長は、米国が主要な臨床研究先として台頭していること、臨床試験での応用を目的とした企業による革新的な製品の発売が増加していることに起因しています。米国は主要な臨床研究先として台頭しています。世界で実施される臨床試験の約半分は米国で行われています。さらに、確立された医療インフラ、迅速な承認スケジュール、有利な規制枠組み、臨床試験で得られたデータの受け入れなどの理由から、ほとんどの製薬研究企業は米国での臨床試験の実施を好んでいます。
北米の臨床試験イメージング市場の収益と2028年までの予測（金額）
北米の臨床試験イメージング市場のセグメンテーション
北米の臨床試験イメージング市場は、モダリティ、オファリング、エンドユーザー、国別に区分されます。
モダリティ別では、北米の臨床試験イメージング市場は、断層撮影、磁気共鳴画像法（MRI）、超音波、陽電子放射断層撮影（PET）、X線、心エコー、その他に区分されます。2023年には、断層撮影セグメントが最大の市場シェアを記録しました。
北米の臨床試験イメージング市場は、提供サービスに基づき、運用イメージングサービス、イメージングソフトウェア、読み取り解析サービス、試験デザインおよびコンサルティングサービス、その他に区分されます。オペレーショナルイメージングサービスセグメントが2023年に最大の市場シェアを占めました。
エンドユーザー別では、北米の臨床試験イメージング市場は、委託研究機関（CRO）、製薬・バイオテクノロジー企業、学術・研究機関、その他に区分されます。2023年には、受託研究機関（CRO）セグメントが最大の市場シェアを占めています。
国別に見ると、市場は米国、カナダ、メキシコに区分されます。米国が2023年の市場シェアを独占しました。
BioTelemetry Inc、Calyx Inc、eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、Medpace Holdings Inc、VIDA Diagnostics Inc、WCG Clinical Incが北米臨床試験イメージング市場で事業を展開する主要企業です。
目次
第1章 イントロダクション
第2章 北米臨床試験イメージング市場-要点
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 北米の臨床試験イメージング市場- 市場情勢
- 北米PEST分析
- 専門家の見解
第5章 北米の臨床試験イメージング市場：主要市場力学
- 市場促進要因
- 製薬・バイオテクノロジー業界における臨床試験活動の加速
- メディカルイメージングサービスを提供するCRO数の急増
- 市場抑制要因
- 高額投資と標準化されたインフラ要件
- 市場機会
- インシリコイメージング臨床試験
- 今後の動向
- AI主導型臨床試験
- インパクト分析
第6章 北米臨床試験イメージング市場
- 北米治験イメージング市場の収益と予測分析
第7章 北米臨床試験イメージング市場の収益と2028年までの予測-モダリティ別
- 北米臨床試験イメージング市場のモダリティ別収益シェア（2022年、2028年）
- トモグラフィ
- 超音波
- ポジトロン断層撮影
- X線
- 心エコー
- 磁気共鳴画像法
- その他
第8章 北米臨床試験イメージング市場の収益と2028年までの予測- 提供
- 北米臨床試験イメージング市場オファリング別収益シェア（2022年および2028年）
- 臨床試験デザインコンサルティングサービス
- 読影分析サービス
- イメージング運用サービス
- イメージング・ソフトウェア
- その他
第9章 北米臨床試験イメージング市場の収益と2028年までの予測-エンドユーザー別
- 製薬会社およびバイオ製薬会社
- 契約研究機関
- 学術・研究機関
- その他
第10章 北米の臨床試験イメージング市場：収益と2028年までの予測：国別分析
- 北米
- 米国
- カナダ
- メキシコ
第11章 臨床試験イメージング市場臨床試験イメージング市場- 業界情勢
- 無機的成長戦略
- 有機的成長戦略
第12章 企業プロファイル
- eResearch Technology Inc
- Calyx Inc
- ICON PLC
- VIDA Diagnostics Inc
- WCG Clinical Inc
- BioTelemetry Inc
- Medical Metrics Inc
- Medpace Holdings Inc
- IXICO plc
第13章 付録
List Of Tables
- Table 1. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Table 2. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
- Table 3. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
- Table 4. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 5. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
- Table 6. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 8. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
- Table 9. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
- Table 10. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 11. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
- Table 12. Recent Organic Growth Strategies in Clinical Trial Imaging Market
- Table 13. Glossary of Terms
List Of Figures
- Figure 1. North America Clinical Trial Imaging Market Segmentation
- Figure 2. North America Clinical Trial Imaging Market, by Country
- Figure 3. North America Clinical Trial Imaging Market Overview
- Figure 4. North America Clinical Trial Imaging Market, By Modality
- Figure 5. North America Clinical Trial Imaging Market, By Country
- Figure 6. North America: PEST Analysis
- Figure 7. North America Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
- Figure 8. North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
- Figure 9. Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 10. Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 11. PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 12. X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 16. North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
- Figure 17. Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 18. Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 22. North America Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
- Figure 23. Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 27. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 28. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
- Figure 29. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 30. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
The North America clinical trial imaging market is expected to grow from US$ 704.94 million in 2023 to US$ 1,025.61 million by 2028; it is estimated to register a CAGR of 7.8% from 2023 to 2028.
Spur in Number of CROs Offering Medical Imaging Services Fuels North America Clinical Trial Imaging Market
Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, a few of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). A few examples of iCROs include Keosys Medical Imaging and Medica Group PLC. CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall North America clinical trial imaging market.
North America Clinical Trial Imaging Market Overview
The North America clinical trial imaging market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trial imaging. The market growth in the region is attributed to the US emerging as a leading clinical research destination and a growing number of innovative product launches by companies for applications in clinical trials. The US has emerged as a leading clinical research destination. Approximately half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data.
North America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
North America Clinical Trial Imaging Market Segmentation
The North America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.
Based on modality, the North America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.
Based on offering, the North America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.
Based on end user, the North America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.
Based on country, the market is segmented into US, Canada, and Mexico. The US dominated the market share in 2023.
BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the North America clinical trial imaging market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trial imaging market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
- develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 North America Market Segmentation
- 1.3.1 North America Clinical Trial Imaging Market - by Modality
- 1.3.2 North America Clinical Trial Imaging Market - by Offering
- 1.3.3 North America Clinical Trial Imaging Market - by End User
- 1.3.4 North America Clinical Trial Imaging Market - by Country
2. North America Clinical Trial Imaging Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Clinical Trial Imaging Market - Market Landscape
- 4.1 Overview
- 4.1.1 North America PEST Analysis
- 4.2 Expert Opinion
5. North America Clinical Trial Imaging Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
- 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
- 5.2 Market Restraints
- 5.2.1 High Investment and Standardized Infrastructure Requirements
- 5.3 Market Opportunities
- 5.3.1 In-Silico Imaging Clinical Trials
- 5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
- 5.5 Impact Analysis
6. North America Clinical Trial Imaging Market
- 6.1 North America Clinical Trial Imaging Market Revenue Forecast and Analysis
7. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality
- 7.1 Overview
- 7.2 North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
- 7.3 Tomography
- 7.3.1 Overview
- 7.3.2 Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Ultrasound
- 7.4.1 Overview
- 7.4.2 Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Positron Emission Tomography
- 7.5.1 Overview
- 7.5.2 PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 X-Ray
- 7.6.1 Overview
- 7.6.2 X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Echocardiography
- 7.7.1 Overview
- 7.7.2 Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8 Magnetic Resonance Imaging
- 7.8.1 Overview
- 7.8.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering
- 8.1 Overview
- 8.2 North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
- 8.3 Trial Design Consulting Services
- 8.3.1 Overview
- 8.3.2 Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Read Analysis Services
- 8.4.1 Overview
- 8.4.2 Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Operational Imaging Services
- 8.5.1 Overview
- 8.5.2 Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Imaging Software
- 8.6.1 Overview
- 8.6.2 Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User
- 9.1 Overview
- 9.2 Pharmaceutical and Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3 Contract Research Organizations
- 9.3.1 Overview
- 9.3.2 Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 Overview
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
- 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
11. Clinical Trial Imaging Market - Industry Landscape
- 11.1 Overview
- 11.2 Inorganic Growth Strategies
- 11.2.1 Overview
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
12. Company Profiles
- 12.1 eResearch Technology Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Calyx Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 ICON PLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 VIDA Diagnostics Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 WCG Clinical Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 BioTelemetry Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Medical Metrics Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Medpace Holdings Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 IXICO plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
